| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Carisma Therapeutics Inc. (CARM) has 1 insider with recent SEC Form 4 filings, including 0 buys and 30 sells. CARM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 57.0K | $1.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Forbes Monica | Chief Financial Officer | Sell | 61,862 | $0.59 | $36,331.55 | -11.4% | |
| Feb 21, 2023 | MacDonald Glen C | Chief Technology Officer | Sell | 25,927 | $0.59 | $15,226.93 | -8.4% | |
| Feb 14, 2017 | McCabe John J | Chief Financial Officer | Sell | 1,399 | $2.10 | $2,937.90 | -19.1% | |
| Sep 28, 2016 | Celniker Abbie | Director | Sell | 10,031 | $3.00 | $30,093.00 | -2.4% | |
| Sep 23, 2016 | Flagship Ventures Fund Iv, L.P. | 10% Owner | Sell | 443,422 | $3.16 | $1,403,297.71 | -14.8% | |
| Sep 21, 2016 | Flagship Ventures Fund Iv, L.P. | 10% Owner | Sell | 386,340 | $3.69 | $1,425,096.88 | -9.6% | |
| Sep 15, 2016 | Flagship Ventures Fund Iv, L.P. | 10% Owner | Sell | 46,692 | $4.18 | $195,118.94 | -1.7% | |
| Sep 7, 2016 | Flagship Ventures Fund Iv, L.P. | 10% Owner | Sell | 129,497 | $4.54 | $588,323.87 | -1.9% | |
| Aug 15, 2016 | McCabe John J | Chief Financial Officer | Sell | 1,170 | $4.80 | $5,616.00 | -13.8% | |
| Jun 27, 2016 | Tubridy Karen L | Chief Development Officer | Sell | 4,372 | $2.08 | $9,093.76 | -11.8% |